Sana Biotechnology (SANA) Total Liabilities (2020 - 2026)

Sana Biotechnology's Total Liabilities history runs 7 years deep, the most recent figure standing at $254.4 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 7.6% year-over-year to $254.4 million; the TTM figure through Mar 2026 stood at $254.4 million (up 7.6% YoY), while the FY2025 annual figure was $256.0 million, up 2.19% from the prior year.
• Total Liabilities came in at $254.4 million for Q1 2026 at Sana Biotechnology, down from $256.0 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $352.1 million in Q2 2023 to a low of $236.4 million in Q1 2025.
• A 5-year average of $286.8 million and a median of $277.8 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities decreased 22.81% in 2025 and grew 7.6% in 2026, its largest moves.
• Sana Biotechnology's Total Liabilities stood at $323.4 million in 2022, then fell by 14.1% to $277.8 million in 2023, then fell by 9.82% to $250.5 million in 2024, then climbed by 2.19% to $256.0 million in 2025, then dropped by 0.65% to $254.4 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $254.4 million, $256.0 million, and $240.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison